NCT07108777View on ClinicalTrials.gov

L-Carnitine Protective Effect in Nephrotoxicity

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 10, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Nephrotoxicity
Interventions
DRUG

L-Carnitine Tartrate

L-carnitine 350 mg three times daily by oral.

DRUG

Placebo

placebo tablet three times daily by oral.

Trial Locations (1)

Unknown

RECRUITING

Menoufia Clinical Oncology Department, Menoufia University., Shibīn al Kawm

All Listed Sponsors
lead

Tanta University

OTHER

NCT07108777 - L-Carnitine Protective Effect in Nephrotoxicity | Biotech Hunter | Biotech Hunter